WESTBROOK — Idexx Laboratories Inc., which makes diagnostic products for veterinarians and tests for livestock and poultry, on Tuesday posted higher second-quarter profits but its stock dropped after it lowered its full-year revenue guidance again.

Second-quarter profits totaled $54 million, or 99 cents per share, up from $51.3 million, or 91 cents per share, a year ago.

The results topped Wall Street analysts’ average earnings expectations of 97 cents a share, according to FactSet.

Quarterly revenue rose 5 percent to $352.6 million from $335.6 million, driven by growth in its pet group. The pet group, known as the companion animal group, had revenues of $295.8 million, up from $278.3 million a year ago.

Sales in the water-testing business rose slightly to $22.4 million from $22.0 million, while sales in the livestock, poultry and dairy sector fell slightly to $28.3 million from $28.6 million a year ago.

For the full year, the Westbrook-based company again cut its full-year guidance, citing increased share repurchases, lower organic revenue growth and unfavorable changes in foreign currency exchange rates.

Idexx now expects to earn $3.42 to $3.48 per share for 2013, compared with a prior range of $3.40 to $3.46. Revenue is expected to be in the range of  $1.37 billion to $1.38 billion, down from its previous forecast of $1.38 billion to $1.39 billion. The company had already trimmed its 2013 outlook earlier this year.

Analysts, on average, expect full-year earnings per share of $3.44 and revenue of $1.38 billion, according to FactSet.

Shares of Idexx fell $1.05 Tuesday, closing at $96.37 on the Nasdaq stock exchange.



Only subscribers are eligible to post comments. Please subscribe or to participate in the conversation. Here’s why.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.